Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$18.67 - $24.56 $130,690 - $171,920
7,000 Added 1.16%
612,975 $14.9 Million
Q4 2022

Feb 14, 2023

BUY
$17.24 - $23.95 $3.53 Million - $4.9 Million
204,499 Added 50.94%
605,975 $13 Million
Q3 2022

Nov 14, 2022

SELL
$9.4 - $18.59 $9,400 - $18,590
-1,000 Reduced 0.25%
401,476 $7.2 Million
Q2 2022

Aug 15, 2022

BUY
$9.12 - $18.9 $948,479 - $1.97 Million
104,000 Added 34.84%
402,476 $3.87 Million
Q1 2022

May 16, 2022

BUY
$12.15 - $16.83 $273,375 - $378,674
22,500 Added 8.15%
298,476 $5.02 Million
Q4 2021

Feb 14, 2022

BUY
$13.83 - $18.78 $824,613 - $1.12 Million
59,625 Added 27.56%
275,976 $4.61 Million
Q3 2021

Nov 15, 2021

BUY
$7.07 - $17.5 $257,348 - $637,000
36,400 Added 20.23%
216,351 $3.51 Million
Q2 2021

Aug 16, 2021

BUY
$5.69 - $7.17 $512,100 - $645,300
90,000 Added 100.05%
179,951 $1.14 Million
Q1 2021

May 17, 2021

BUY
$5.08 - $6.89 $106,680 - $144,690
21,000 Added 30.46%
89,951 $556,000
Q4 2020

Feb 16, 2021

SELL
$5.65 - $7.66 $1.43 Million - $1.94 Million
-253,549 Reduced 78.62%
68,951 $476,000
Q3 2020

Nov 16, 2020

SELL
$4.01 - $6.29 $140,350 - $220,150
-35,000 Reduced 9.79%
322,500 $1.82 Million
Q2 2020

Aug 14, 2020

BUY
$3.06 - $6.6 $1.09 Million - $2.36 Million
357,500 New
357,500 $1.82 Million

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.